Compound Detail
CHEMBL27
PROPRANOLOL 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL27 |
| Name | PROPRANOLOL |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | AQHHHDLHHXJYJD-UHFFFAOYSA-N |
| Therapeutic | ✓ Yes |
39
Targets
148
Activities
4
Assay Types
30
PK Parameters
20
Publications
10
Known Names
20
Indications
Molecular Properties
259.4
MW (Da)
2.58
ALogP
3
HBA
2
HBD
41.5
PSA (Ų)
0.84
QED
0
Ro5 Violations
6
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1967 |
| Availability | Prescription |
| Chirality | Racemic |
Indications
Cardiovascular Diseases Arrhythmias, Cardiac Ascites Brain Injuries Colorectal Neoplasms Coronary Disease Death, Sudden, Cardiac Esophageal and Gastric Varices Headache Heart Diseases Hemangioma Hypertension, Portal Liver Cirrhosis Migraine Disorders Myocardial Infarction Myocardial Ischemia Smoking Cessation Stress Disorders, Post-Traumatic Tachycardia, Supraventricular Telangiectasia, Hereditary Hemorrhagic
ATC Classification
C07AA05
propranolol
Level 1: CARDIOVASCULAR SYSTEM
Level 2: BETA BLOCKING AGENTS
Activity Summary
Kd 64 meas. best 10.0
IC50 44 meas. best 9.32
Ki 37 meas. best 9.49
EC50 3 meas. best 4.5
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Beta-2 adrenergic receptor CHEMBL210 | Kd | 10.0 | 8.952 | 0.1 | 5 |
| Beta-2 adrenergic receptor CHEMBL210 | Ki | 9.49 | 9.028 | 0.3 | 5 |
| Beta-2 adrenergic receptor CHEMBL210 | IC50 | 9.32 | 8.7075 | 0.5 | 4 |
| Beta-2 adrenergic receptor CHEMBL5414 | Kd | 9.01 | 8.2958 | 1.0 | 12 |
| Cavia porcellus CHEMBL369 | Kd | 8.9 | 8.4233 | 1.3 | 6 |
| Adrenergic receptor beta CHEMBL2094118 | Kd | 8.9 | 8.665 | 1.3 | 4 |
| Beta-1 adrenergic receptor CHEMBL213 | Ki | 8.85 | 8.5625 | 1.4 | 4 |
| Unchecked CHEMBL612545 | Kd | 8.81 | 8.4467 | 1.5 | 3 |
| Beta-1 adrenergic receptor CHEMBL5471 | Kd | 8.76 | 8.3086 | 1.7 | 14 |
| Beta-2 adrenergic receptor CHEMBL2289 | Kd | 8.75 | 8.75 | 1.8 | 1 |
| Beta-1 adrenergic receptor CHEMBL213 | Kd | 8.74 | 7.8867 | 1.8 | 3 |
| Adrenergic receptor beta CHEMBL2095166 | Ki | 8.62 | 7.5367 | 2.4 | 3 |
| Beta-1 adrenergic receptor CHEMBL3252 | Kd | 8.62 | 7.73 | 2.4 | 4 |
| Beta-1 adrenergic receptor CHEMBL3440 | Ki | 8.62 | 8.62 | 2.4 | 1 |
| Beta-1 adrenergic receptor CHEMBL213 | IC50 | 8.6 | 7.65 | 2.5 | 3 |
| Adrenergic receptor beta CHEMBL2095166 | IC50 | 8.52 | 8.02 | 3.0 | 2 |
| Beta-1 adrenergic receptor CHEMBL3252 | Ki | 8.52 | 7.5111 | 3.0 | 9 |
| Adrenergic receptor beta CHEMBL2094118 | IC50 | 8.4 | 8.16 | 4.0 | 2 |
| Unchecked CHEMBL612545 | Ki | 8.15 | 6.91 | 7.0 | 2 |
| Canis familiaris CHEMBL373 | Kd | 7.95 | 7.66 | 11.2 | 3 |
| Beta-2 adrenergic receptor CHEMBL2289 | IC50 | 7.77 | 7.77 | 17.0 | 1 |
| Beta-2 adrenergic receptor CHEMBL5414 | IC50 | 7.54 | 7.54 | 28.8 | 1 |
| Beta-1 adrenergic receptor CHEMBL5471 | IC50 | 7.46 | 7.46 | 34.7 | 1 |
| 5-hydroxytryptamine receptor 1B CHEMBL3459 | Ki | 7.3 | 7.3 | 50.0 | 1 |
| 5-hydroxytryptamine receptor 1A CHEMBL273 | Ki | 7.05 | 6.9533 | 90.0 | 3 |
| Beta-3 adrenergic receptor CHEMBL246 | Ki | 7.0 | 7.0 | 99.0 | 1 |
| Beta-3 adrenergic receptor CHEMBL246 | IC50 | 6.88 | 6.88 | 132.0 | 1 |
| Beta-3 adrenergic receptor CHEMBL246 | Kd | 6.79 | 6.73 | 162.2 | 2 |
| Sodium-dependent serotonin transporter CHEMBL228 | Ki | 6.7 | 6.7 | 202.0 | 1 |
| 5-hydroxytryptamine receptor 2B CHEMBL1833 | Ki | 6.66 | 6.66 | 218.0 | 1 |
| 5-hydroxytryptamine receptor 1A CHEMBL273 | IC50 | 6.61 | 6.61 | 243.0 | 1 |
| 5-hydroxytryptamine receptor 2B CHEMBL1833 | IC50 | 6.47 | 6.47 | 342.0 | 1 |
| Sodium-dependent serotonin transporter CHEMBL228 | IC50 | 6.42 | 6.42 | 380.0 | 1 |
| 5-hydroxytryptamine receptor 2A CHEMBL224 | Ki | 6.38 | 6.38 | 419.0 | 1 |
| Nuclear receptor subfamily 2 group E member 1 CHEMBL1961788 | Kd | 6.3 | 6.3 | 500.0 | 1 |
| Sigma non-opioid intracellular receptor 1 CHEMBL287 | Ki | 5.92 | 5.92 | 1206.0 | 1 |
| 5-hydroxytryptamine receptor 2C CHEMBL225 | Ki | 5.92 | 5.92 | 1202.0 | 1 |
| 5-hydroxytryptamine receptor 6 CHEMBL3371 | Ki | 5.85 | 5.85 | 1423.0 | 1 |
| 5-hydroxytryptamine receptor 2A CHEMBL224 | IC50 | 5.83 | 5.83 | 1466.0 | 1 |
| Cytochrome P450 2D6 CHEMBL289 | IC50 | 5.72 | 5.5733 | 1900.0 | 3 |
| Sodium channel protein type 5 subunit alpha CHEMBL1980 | IC50 | 5.68 | 5.68 | 2100.0 | 1 |
| 5-hydroxytryptamine receptor 2C CHEMBL225 | IC50 | 5.64 | 5.64 | 2294.0 | 1 |
| Voltage-gated inwardly rectifying potassium channel KCNH2 CHEMBL240 | IC50 | 5.55 | 5.55 | 2828.0 | 1 |
| Sigma non-opioid intracellular receptor 1 CHEMBL287 | IC50 | 5.54 | 5.54 | 2870.0 | 1 |
| 5-hydroxytryptamine receptor 6 CHEMBL3371 | IC50 | 5.51 | 5.51 | 3065.0 | 1 |
| Unchecked CHEMBL612545 | IC50 | 5.46 | 5.46 | 3467.0 | 1 |
| Cytochrome P450 1A2 CHEMBL3356 | IC50 | 5.4 | 5.4 | 4000.0 | 1 |
| 5-hydroxytryptamine receptor 1A CHEMBL214 | IC50 | 5.4 | 5.4 | 3981.1 | 1 |
| Hepatic sodium/bile acid cotransporter CHEMBL5287 | IC50 | 5.26 | 5.26 | 5500.0 | 1 |
| Plasmodium falciparum CHEMBL364 | IC50 | 4.99 | 4.705 | 10190.0 | 2 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 92.0 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 34.0 | mL.min-1.kg-1 | Canis lupus familiaris |
| CL | 13.0 | mL.min-1.kg-1 | Homo sapiens |
| CL | 80.0 | mL.min-1.g-1 | Homo sapiens |
| CL | 16.11 | mL.min-1.kg-1 | Homo sapiens |
| CL | 12.0 | mL.min-1.kg-1 | Homo sapiens |
| CL | 10.8 | mL.min-1.kg-1 | Homo sapiens |
| CL | 12.0 | mL.min-1.kg-1 | Homo sapiens |
| CL | 92.0 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 12.0 | mL.min-1.kg-1 | Homo sapiens |
| CL | 14.0 | mL.min-1.kg-1 | Macaca |
| CL | 15.0 | mL.min-1.kg-1 | Homo sapiens |
| CL | 34.0 | mL.min-1.kg-1 | Canis lupus familiaris |
| CL | 121.0 | mL.min-1.g-1 | Mus musculus |
| CL | 121.0 | mL.min-1.g-1 | Mus musculus |
| CL | 13.0 | mL.min-1.kg-1 | Homo sapiens |
| CL | 18.3 | mL.min-1.kg-1 | Homo sapiens |
| CL | 914.5 | mL.min-1.g-1 | Mus musculus |
| CL | 3600.9 | mL.min-1.kg-1 | Mus musculus |
| CL | 87.8 | mL.min-1.kg-1 | Mus musculus |
| CL | 2.7e-05 | mL.min-1.g-1 | Homo sapiens |
| CL | 4e-06 | mL.min-1.g-1 | Homo sapiens |
| CL | 260.0 | mL.min-1.kg-1 | Homo sapiens |
| CL | 48.6 | uL.min-1.(10^6cells)-1 | Homo sapiens |
| CL | 13.2 | mL.min-1.kg-1 | Homo sapiens |
| CL | 132.0 | mL.min-1.kg-1 | Homo sapiens |
| CL | 0.7 | mL.min-1.kg-1 | Homo sapiens |
| CL | 20.0 | mL.min-1.kg-1 | Homo sapiens |
| CL | 11.31 | mL.min-1.g-1 | Rattus norvegicus |
| CL | 7.5 | mL.min-1.g-1 | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine